Shuhua Yi
机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Academy of Fine Arts, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0002-6291-812X
发表论文 559 篇 · 总被引 2267 次 · h-index 26
代表论文
- Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (2025 · Journal of Clinical Oncology · 被引 18)
- Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma (2025 · Advanced Science · 被引 1)
- Primary analysis of a multicenter, open-label, phase 2 study of sonrotoclax (BGB-11417) monotherapy in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) (2025 · Blood · 被引 1)
- Continuous or fixed-duration BTK inhibitor treatment for WM (2026 · Blood Advances)
- Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial (2026 · Signal Transduction and Targeted Therapy)
- MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications (2026 · Leukemia)